Physician profile
Kendra Storer
NPI 1780021758
$6,828.47
in general payments reported to CMS, 2019-2025
27 companies · $777 in 2025
The $777 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.26 · 2022: $612 · 2023: $4,022 · 2024: $1,386 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,410 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,795 · Travel and Lodging: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,410.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,795.00 |
| Travel and Lodging | $979.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,599.04 | 2021-2024 | Pulseselect, Pulseselect, Micra |
| Abbott Laboratories | $780.84 | 2022-2024 | Ensite, Aveir, Quadra Allure Mp |
| Boston Scientific Corporation | $773.68 | 2022-2025 | General - Therapies, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Pfizer INC. | $185.58 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $166.81 | 2022-2025 | Brilinta, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $143.17 | 2023-2025 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $117.64 | 2024 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $98.26 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $95.94 | 2024-2025 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $95.93 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $86.36 | 2022-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.96 | 2022-2024 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $78.85 | 2022-2025 | Evkeeza |
| Amgen INC. | $78.63 | 2023-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $68.40 | 2022-2024 | Xarelto |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $63.96 | 2025 | Attruby |
| Novo Nordisk INC | $63.84 | 2023-2025 | Wegovy, Ozempic |
| Kestra Medical Technology Services, INC. | $47.19 | 2024-2025 | Assure Wcd |
| Teleflex LLC | $38.08 | 2022-2024 | Guideliner |
| Lexicon Pharmaceuticals, INC. | $27.29 | 2024 | |
| Philips North America LLC | $25.19 | 2025 | Lm Undivided |
| Cardiovascular Systems INC. | $24.30 | 2023 | Diamondback Peripheral |
| Integra Lifesciences Corporation | $24.15 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Alnylam Pharmaceuticals INC. | $20.58 | 2025 | Amvuttra |
| Convatec INC. | $17.14 | 2025 | Aquacel Ag Surgical |
| Chiesi USA, INC. | $13.39 | 2023 | Cleviprex, Kengreal |
| Actelion Pharmaceuticals US, INC. | $13.27 | 2024 | Uptravi, Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Storer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.